Douglas A. Rich
Keine laufenden Positionen mehr
Vermögen: 9 617 $ am 30.11.2023
Profil
Douglas A.
Rich served as Senior Vice President-Operations at Kythera Biopharmaceuticals LLC.
He then worked as Vice President-Quality at Boehringer Ingelheim Corp.
from 2011 to 2014.
Later, he served as Senior Vice President-Operations at Unity Biotechnology, Inc. Mr. Rich is currently working as Chief Technical Officer at Applied Molecular Transport, Inc. from 2021 to 2023.
He completed his undergraduate degree from the University of Southern California and earned an MBA from Pepperdine University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
01.03.2023 | 49 316 ( 0,12% ) | 9 617 $ | 30.11.2023 |
Ehemalige bekannte Positionen von Douglas A. Rich
Unternehmen | Position | Ende |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.12.2023 |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01.01.2014 |
UNITY BIOTECHNOLOGY, INC. | Geschäftsführer | - |
KYTHERA BIOPHARMACEUTICALS INC | Geschäftsführer | - |
Ausbildung von Douglas A. Rich
University of Southern California | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
UNITY BIOTECHNOLOGY, INC. | Health Technology |
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Kythera Biopharmaceuticals LLC
Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |